Can n-3 fatty acids provide myocardial protection by decreasing infarct size and inhibiting atherothrombosis?

European Heart Journal, Supplement

Volumn 3, Issue SUPPL.4, 2001, Pages

  Singh, R B ^a   Niaz, M A ^a   Kartik, C ^b  

^a Medical Hospital and Research Centre Moradabad   (India)

^b SUBHARTI MEDICAL COLLEGE   (India)

Author keywords

Bioenergetic; Coenzyme Q10; Electrocardiographic; Fish oil; Oxidative stress

Indexed keywords

EID: 4243385912     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(01)90122-1     Document Type: Article

References (37)

1. White HD. Future of reperfusion therapy for acute myocardial infarction. Lancet 1999; 354: 695-7.
2. Khatter RS, Basu SK, Senior R, Lahiri A. Prognostic value of predischarge exercise testing, ejection fraction and ventricular ectopic activity in acute myocardial infarction. Am J Cardiol 1996; 78: 136-41.
3. Senior R, Basu S, Kinsey C, Schaffer S, Lahiri A. Carvedilol prevents remodelling in patients with left ventricular dysfunction after acute myocardial infarction. Am Heart J 1999; 137: 646-52.
4. Kobayashi Y, Goto Y, Daikoku S et al. Cardioprotective effects of intravenous nicorondil in patients with successful reperfusion for acute myocardial infarction. Jpn Circ J 1998; 62: 183-9.
5. Yusuf S, Slight P, Rossi P et al. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction. Circulation 1983; 67: 132-41.
6. Feuerstein GZ, Hamberger SA, Smith EF, Bril A, Ruffolo RR. Myocardial protection with carvedilol. J Cardiovasc Pharmacol 1992; 19 (Suppl): 38-41.
7. Mancini GBJ. Role of angiotensin-converting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease. Am J Med 1998; 105 (Suppl 1A): 40-7.
8. Singh RB, Wander GS, Rastogi A et al. Randomized, double blind, placebo controlled trial of Q10 in patients with acute myocardial infarction. Cardiovasc Drug Ther 1998; 12: 347-53.
9. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447-55.
10. Singh RB. GISSI Prevenzione Trial (letter). Lancet 1999; 354: 1556.
11. De Lorgeril M, Salen M, Martin JL, Monlaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99: 779-85.
12. Singh RB, Niaz MA, Sharma JP et al. Randomized double blind, placebo controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian Experiment of Infarct Survival-4. Cardiovasc Drug Ther 1997; 11: 485-91.
13. Landmark K, Abdelnoor M, Urdal P et al. Use of fish oil appears to reduce infarct size as estimated from peak creatinine kinase and lactate dehydrogenase activities. Cardiology 1998; 89: 94-102.
14. Sellmayer A, Witzgall H, Lorenz RL, Weber PC. Effects of dietary fish oil on ventricular premature complexes. Am J Cardiol 1995; 76: 974-7.
15. von Shacky C, Angerer P, Kothny W, Theisen K, Mudra H. The effect of n-3 fatty acids on coronary atherosclerosis. A randomized, double blind, placebo controlled trial. Ann Int Med 1999; 130: 554-62.
16. Singh RB, Niaz MA, Agarwal P, Beegum R, Rastogi SS. Effect of antioxidant rich foods on plasma ascorbic acid, cardiac enzyme and lipid peroxide levels in patients hospitalized with acute myocardial infarction. J Am Diet Assoc 1995; 95: 775-80.
17. Singh RB, Rastogi SS, Verma R, Bolaki L, Singh R, Ghosh S. An Indian experiment with nutritional modulation in acute myocardial infarction. Am J Cardiol 1992; 69: 879-85.
18. Singh RB, Rastogi SS, Verma R et al. Randomized, controlled trial of cardioprotective diet in patients with acute myocardial infarction: results of one year follow up. Br Med J 1992; 304: 1015-9.
19. Culp BR, Lands WEM, Luchesi BR, Patt B, Romson J. The effect of dietary supplementation of fish oil on experimental myocardial infarction. Prostaglandins 1980; 20: 1020-31.
20. Hock CE, Holaban ME, Reibel DK. Effect of dietary fish oil on myocardial phospholipids and myocardial ischaemic damage. Am J Physiol 1987; 252: H554-H560.
21. Matsukura T, Miyagawa M, Satoh K, Mineo S, Yanagisawa A, Ishikawa K. Effect of dietary fish oil on infarct size in feline myocardial ischaemia. Circulation 1990; 82 (Suppl III): 111-39.
22. Oskarsson HJ, Gowin J, Gunnar RM, Thomas JX Jr. Dietary fish supplementation reduces myocardial infarct size in canine model of ischaemia and reperfusion. J Am Coll Cardiol 1993; 21: 1280-5.
23. Zhu BQ, Sievers RE, Sun YP, Morsh-Fishure N, Parmley WW, Wolfe CL. Is the reduction of myocardial infarct size by dietary fish oil the result of altered platelet function? Am Heart J 1994; 127: 744-55.
24. Black KL, Culp B, Medison D, Randall OS, Lands WEM. The protective effects of dietary fish oil on focal infarction. Prostaglandins Med 1979; 3: 257-68.
25. Marangoni F, Angeli MT, Tarantino A, Bonabello A, Galli C. Transcutaneous absorption and incorporation of 3(H) EPA (20:5, n-3) in lipids of subcutaneous fluid, plasma and liver in the rat. In: Drevon CA, Baaksaas I, Krokan HE, eds. Omega-3 Fatty Acids: Metabolism and Biological Effects. Switzerland: Birkhauser Verlag, 1993: 35-40.
26. Burr ML, Fehily AM, Gilbert JF et al. Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART). Lancet 1989; ii: 757-61.
27. Enas EA, Yusuf S. Third meeting of the international working group on coronary artery disease in south Asians. Indian Heart J 1999; 51: 99-103.
28. Grande P, Christiansen C, Alstrup K. Comparison of ASAT, CK, CK-MB, and LD for the estimation of acute myocardial infarction in man. Clin Chim Acta 1983; 128: 329-35.
29. Hindman N, Grande P, Harrell FE Jr, Anderson C, Harrison D, Ideker RE, Selvester RH, Wagner GS. Relation between electrocardiographic and enzymatic methods of estimating acute myocardial infarct size. Am J Cardiol 1986; 58: 31-5.
30. Alderich EA. Use of initial ST segment elevation as an indicator of final infarct size. Am J Cardiol 1988; 343: 12-6.
31. Dyerberg J, Bang HO, Stofferson E. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis. Lancet 1978; ii: 117-9.
32. Aursnes I, Derum HP, Smith P et al. Low and high risk coronary patients discriminated by blood platelets fatty acid composition. Scand J Clin Lab Invest 1986; 46: 115-20.
33. Gudbjarnason S. Dynamics of n-3 and n-6 fatty acids in phospholipids of heart muscle. J Int Med 1989; 225 (Suppl 1): 117-28.
34. Schacky CV, Fischer S, Weber PC. Long term effects of dietary marine n-3 fatty acids upon plasma and cellular lipids, platelet function and eicosanoid formation in humans. J Clin Invest 1985; 76: 1626-31.
35. Mehta J, Lawson D, Saldeen T. Reduction in plasminogen activator inhibitor-1(PAI-1) with n-3 polyunsaturated fatty acids intake. Am Heart J 1988; 116: 1201-6.
36. Shimokawa H, Vanhoutte PM. Dietary cod-liver oil improves endothelium dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1988; 78: 1421-30.
37. Eritsland J, Arnesen H, Gronseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 1996; 77: 31-6.